Publications

Author

Title

Year sorteringsordning

Fulltext

Brunström, Mattias
Dahlström, John
Lindholm, Lars Hjalmar; et al.

From efficacy in trials to effectiveness in clinical practice: The Swedish Stroke Prevention Study
Blood Pressure, 25(4): 206-211

2016

-

Lindholm, Lars H.
Carlberg, Bo

The new Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014): a giant undertaking
Hypertension Research, 37(4): 391-392

2014

-

Smink, P. A.
Hoekman, J.
Grobbee, D. E.; et al.

A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers
European Journal of Preventive Cardiology, 21(4): 434-441

2014

-

Weber, Michael A
Schiffrin, Ernesto L
White, William B; et al.

Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the International society of hypertension
The Journal of Clinical Hypertension, 16(1): 14-26

2014

-

Weber, Michael A.
Schiffrin, Ernesto L.
White, William B.; et al.

Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
Journal of Hypertension, 32(1): 3-15

2014

-

Okin, PM
Hille, DA
Wiik, BP; et al.

In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: the LIFE study
Diabetic Medicine, 30(10): 1189-1197

2013

-

Ruwald, Anne Christine H.
Westergaard, Bo
Sehestedt, Thomas; et al.

Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
Journal of Hypertension, 30(6): 1252-1259

2012

-

Okin, Peter M.
Kjeldsen, Sverre E.
Lindholm, Lars H.; et al.

The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium
Blood Pressure, 21(3): 146-152

2012

-

Olsen, Michael H.
Wachtell, Kristian
Ibsen, Hans; et al.

Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
Journal of Hypertension, 29(5): 997-1004

2011

-

Teo, Koon K.
Sleight, Peter
Gao, Peggy; et al.

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
Journal of Hypertension, 29(4): 623-635

2011

-